Drugs & TargetsFree FDA issues alert about increased risk of death associated with Pepaxto July 30, 2021Vol.47 No.30
Capitol HillFree Institutions will be required to report sexual misconduct to NIH if House committee bill becomes law July 23, 2021Vol.47 No.29By Matthew Bin Han Ong
Conversation with The Cancer LetterFreeHealth Equity To combat health disparities in communities of color, City of Hope recruits its most diverse class for leadership training in 2021 July 23, 2021Vol.47 No.29By Matthew Bin Han Ong
Cancer History ProjectConversation with The Cancer LetterFree Bob Young tells us about the evolution of consortium cancer centers since the signing of the National Cancer Act July 23, 2021Vol.47 No.29By Paul Goldberg
FreeGuest EditorialIn the Archives The National Cancer Act of 1971 and the birth of NCI-Designated Cancer Centers July 23, 2021Vol.47 No.29By Donald L. "Skip" Trump and Eric T. Rosenthal
Conversation with The Cancer LetterFreeHealth Equity Peter Pisters: I want MD Anderson to be seen as an exemplar in our work on diversity, equity, and inclusion July 16, 2021Vol.47 No.28By Matthew Bin Han Ong
FreeIn the Archives Edward Kennedy: The 20th anniversary of the National Cancer Act of 1971 July 16, 2021Vol.47 No.28
FreeHealth Equity To address disparities, Cleveland health systems re-imagine diversity, inclusion, equity efforts at the executive level July 09, 2021Vol.47 No.27By Matthew Bin Han Ong
Cancer History ProjectFree To NCI designation through difficulty: How KU’s Roy Jensen made it happen July 09, 2021Vol.47 No.27By Paul Goldberg
FreeIn the Archives Which cancer center was first? The answer depends on what you mean by “cancer center” July 09, 2021Vol.47 No.27By Katie Goldberg